Nuclear envelope regulation of signaling cascades

Advances in Experimental Medicine and Biology

Volumn 773, Issue , 2014, Pages 187-206

  Choi, Jason C ^a   Worman, Howard J ^a  

^a Columbia University ^*  (United States)

Author keywords

Inner nuclear membrane; Integral membrane proteins; Laminopathies; Lamins; Nuclear envelope; Nuclear lamina; Nucleus; Signal transduction

Indexed keywords

EMERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMIN A; LAMIN C; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN MAN1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL NUCLEUS MEMBRANE; CYTOLOGY; EXON; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENOME; HUMAN; LAMINOPATHY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PATHOGENESIS; PRIORITY JOURNAL; PROGERIA; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

EID: 84934442756     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-8032-8_9     Document Type: Article

References (131)

1. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL (2005) The nuclear lamina comes of age. Nat Rev Mol Cell Biol 6(1):21-31. doi: 10.1038/nrm1550
2. Stewart CL, Roux KJ, Burke B (2007) Blurring the boundary: the nuclear envelope extends its reach. Science 318(5855):1408-1412. doi: 10.1126/science.1142034
3. Terry LJ, Shows EB, Wente SR (2007) Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318(5855):1412-1416. doi: 10.1126/science.1142204
4. Schirmer EC, Gerace L (2005) The nuclear membrane proteome: extending the envelope. Trends Biochem Sci 30(10):551-558. doi: 10.1016/j.tibs.2005.08.003
5. Cascianelli G, Villani M, Tosti M, Marini F, Bartoccini E, Magni MV, Albi E (2008) Lipid microdomains in cell nucleus. Mol Biol Cell 19(12):5289-5295. doi: 10.1091/mbc. E08-05-0517
6. Ledeen RW, Wu G (2004) Nuclear lipids: key signaling effectors in the nervous system and other tissues. J Lipid Res 45(1):1-8. doi: 10.1194/jlr.R300015-JLR200
7. Datta K, Guan T, Gerace L (2009) NET37, a nuclear envelope transmembrane protein with glycosidase homology, is involved in myoblast differentiation. J Biol Chem 284(43):29666-29676. doi: 10.1074/jbc.M109.034041
8. Huber MD, Guan T, Gerace L (2009) Overlapping functions of nuclear envelope proteins NET25 (Lem2) and emerin in regulation of extracellular signal-regulated kinase signaling in myoblast differentiation. Mol Cell Biol 29(21):5718-5728. doi: 10.1128/MCB.00270-09
9. Liu GH, Guan T, Datta K, Coppinger J, Yates J 3rd, Gerace L (2009) Regulation of myoblast differentiation by the nuclear envelope protein NET39. Mol Cell Biol 29(21):5800-5812. doi: 10.1128/MCB.00684-09
10. Schirmer EC, Florens L, Guan T, Yates JR 3rd, Gerace L (2003) Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science 301(5638):1380-1382. doi: 10.1126/science.1088176
11. Korfali N, Wilkie GS, Swanson SK, Srsen V, de Las Heras J, Batrakou DG, Malik P, Zuleger N, Kerr AR, Florens L, Schirmer EC (2012) The nuclear envelope proteome differs notably between tissues. Nucleus 3(6):552-564. doi: 10.4161/nucl.22257
12. Aebi U, Cohn J, Buhle L, Gerace L (1986) The nuclear lamina is a meshwork of intermediatetype fi laments. Nature 323(6088):560-564. doi: 10.1038/323560a0
13. Fisher DZ, Chaudhary N, Blobel G (1986) cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate fi lament proteins. Proc Natl Acad Sci USA 83(17):6450-6454
14. Goldman AE, Maul G, Steinert PM, Yang HY, Goldman RD (1986) Keratin-like proteins that coisolate with intermediate fi laments of BHK-21 cells are nuclear lamins. Proc Natl Acad Sci USA 83(11):3839-3843
15. McKeon FD, Kirschner MW, Caput D (1986) Homologies in both primary and secondary structure between nuclear envelope and intermediate fi lament proteins. Nature 319(6053):463-468. doi: 10.1038/319463a0
16. Burke B, Stewart CL (2013) The nuclear lamins: fl exibility in function. Nat Rev Mol Cell Biol 14(1):13-24. doi: 10.1038/nrm3488
17. Wilson KL, Foisner R (2010) Lamin-binding proteins. Cold Spring Harb Perspect Biol 2(4):a000554. doi: 10.1101/cshperspect.a000554
18. Worman HJ, Foisner R (2010) The nuclear envelope from basic biology to therapy. Biochem Soc Trans 38(Pt 1):253-256. doi: 10.1042/BST0380253
19. Dauer WT, Worman HJ (2009) The nuclear envelope as a signaling node in development and disease. Dev Cell 17(5):626-638. doi: 10.1016/j.devcel.2009.10. 016
20. Peter M, Kitten GT, Lehner CF, Vorburger K, Bailer SM, Maridor G, Nigg EA (1989) Cloning and sequencing of cDNA clones encoding chicken lamins A and B1 and comparison of the primary structures of vertebrate A-and B-type lamins. J Mol Biol 208(3):393-404
21. Furukawa K, Hotta Y (1993) cDNA cloning of a germ cell specifi c lamin B3 from mouse spermatocytes and analysis of its function by ectopic expression in somatic cells. EMBO J 12(1):97-106
22. Furukawa K, Inagaki H, Hotta Y (1994) Identifi cation and cloning of an mRNA coding for a germ cell-specifi c A-type lamin in mice. Exp Cell Res 212(2):426-430. doi: 10.1006/excr.1994.1164
23. Broers JL, Machiels BM, Kuijpers HJ, Smedts F, van den Kieboom R, Raymond Y, Ramaekers FC (1997) A-and B-type lamins are differentially expressed in normal human tissues. Histochem Cell Biol 107(6):505-517
24. Lehner CF, Stick R, Eppenberger HM, Nigg EA (1987) Differential expression of nuclear lamin proteins during chicken development. J Cell Biol 105(1):577-587
25. Stewart C, Burke B (1987) Teratocarcinoma stem cells and early mouse embryos contain only a single major lamin polypeptide closely resembling lamin B. Cell 51(3):383-392
26. Rober RA, Weber K, Osborn M (1989) Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 105(2):365-378
27. Worman HJ (2012) Nuclear lamins and laminopathies. J Pathol 226(2):316-325. doi: 10.1002/path.2999
28. Butin-Israeli V, Adam SA, Goldman AE, Goldman RD (2012) Nuclear lamin functions and disease. Trends Genet 28(9):464-471. doi: 10.1016/j.tig.2012.06. 001
29. Chow KH, Factor RE, Ullman KS (2012) The nuclear envelope environment and its cancer connections. Nat Rev Cancer 12(3):196-209. doi: 10.1038/nrc3219
30. Lin F, Worman HJ (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 268(22):16321-16326
31. Machiels BM, Zorenc AH, Endert JM, Kuijpers HJ, van Eys GJ, Ramaekers FC, Broers JL (1996) An alternative splicing product of the lamin A/C gene lacks exon 10. J Biol Chem 271(16):9249-9253
32. Fong LG, Ng JK, Lammerding J, Vickers TA, Meta M, Cote N, Gavino B, Qiao X, Chang SY, Young SR, Yang SH, Stewart CL, Lee RT, Bennett CF, Bergo MO, Young SG (2006) Prelamin A and lamin A appear to be dispensable in the nuclear lamina. J Clin Invest 116(3):743-752. doi: 10.1172/JCI27125
33. Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, Goldman RD (2008) Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 22(7):832-853. doi: 10.1101/gad.1652708
34. Stuurman N, Heins S, Aebi U (1998) Nuclear lamins: their structure, assembly, and interactions. J Struct Biol 122(1-2):42-66. doi: 10.1006/jsbi.1998.3987
35. Dhe-Paganon S, Werner ED, Chi YI, Shoelson SE (2002) Structure of the globular tail of nuclear lamin. J Biol Chem 277(20):17381-17384. doi: 10.1074/jbc.C200038200
36. Krimm I, Ostlund C, Gilquin B, Couprie J, Hossenlopp P, Mornon JP, Bonne G, Courvalin JC, Worman HJ, Zinn-Justin S (2002) The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10(6):811-823
37. Beck LA, Hosick TJ, Sinensky M (1990) Isoprenylation is required for the processing of the lamin A precursor. J Cell Biol 110(5):1489-1499
38. Kitten GT, Nigg EA (1991) The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2. J Cell Biol 113(1):13-23
39. Sinensky M, Fantle K, Trujillo M, McLain T, Kupfer A, Dalton M (1994) The processing pathway of prelamin A. J Cell Sci 107(Pt 1):61-67
40. Young SG, Fong LG, Michaelis S (2005) Prelamin A, Zmpste24, misshapen cell nuclei, and progeria-new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res 46(12):2531-2558. doi: 10.1194/jlr.R500011-JLR200
41. Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241-269. doi: 10.1146/annurev.bi. 65.070196.001325
42. Clarke S (1992) Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu Rev Biochem 61:355-386. doi: 10.1146/annurev.bi.61.070192.002035
43. Krohne G, Waizenegger I, Hoger TH (1989) The conserved carboxy-terminal cysteine of nuclear lamins is essential for lamin association with the nuclear envelope. J Cell Biol 109(5):2003-2011
44. Holtz D, Tanaka RA, Hartwig J, McKeon F (1989) The CaaX motif of lamin A functions in conjunction with the nuclear localization signal to target assembly to the nuclear envelope. Cell 59(6):969-977
45. Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21(3):285-288. doi: 10.1038/6799
46. Ostlund C, Bonne G, Schwartz K, Worman HJ (2001) Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J Cell Sci 114(Pt 24):4435-4445
47. Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI, Lovett M, Bowcock AM (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet 66(4):1192-1198. doi: 10.1086/302836
48. Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, Schmidt H, Brabant G, Kumar S, Durrington PN, Gregory S, O'Rahilly S, Trembath RC (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24(2):153-156. doi: 10.1038/72807
49. Cao H, Hegele RA (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 9(1):109-112
50. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Levy N (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300(5628):2055. doi: 10.1126/science.1084125
51. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423(6937):293-298. doi: 10.1038/nature01629
52. Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, Hultenby K, Astudillo A, Wernerson A, Rodriguez F, Tryggvason K, Lopez-Otin C (2002) Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-defi cient mice. Nat Genet 31(1):94-99. doi: 10.1038/ng871
53. Bergo MO, Gavino B, Ross J, Schmidt WK, Hong C, Kendall LV, Mohr A, Meta M, Genant H, Jiang Y, Wisner ER, Van Bruggen N, Carano RA, Michaelis S, Griffey SM, Young SG (2002) Zmpste24 defi ciency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci USA 99(20):13049-13054. doi: 10.1073/pnas.192460799
54. Navarro CL, Cadinanos J, De Sandre-Giovannoli A, Bernard R, Courrier S, Boccaccio I, Boyer A, Kleijer WJ, Wagner A, Giuliano F, Beemer FA, Freije JM, Cau P, Hennekam RC, Lopez-Otin C, Badens C, Levy N (2005) Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum Mol Genet 14(11):1503-1513. doi: 10.1093/hmg/ddi159
55. Navarro CL, De Sandre-Giovannoli A, Bernard R, Boccaccio I, Boyer A, Genevieve D, Hadj-Rabia S, Gaudy-Marqueste C, Smitt HS, Vabres P, Faivre L, Verloes A, Van Essen T, Flori E, Hennekam R, Beemer FA, Laurent N, Le Merrer M, Cau P, Levy N (2004) Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 13(20):2493-2503. doi: 10.1093/hmg/ddh265
56. Fong LG, Frost D, Meta M, Qiao X, Yang SH, Coffinier C, Young SG (2006) A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 311(5767):1621-1623. doi: 10.1126/science.1124875
57. Yang SH, Meta M, Qiao X, Frost D, Bauch J, Coffinier C, Majumdar S, Bergo MO, Young SG, Fong LG (2006) A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest 116(8):2115-2121. doi: 10.1172/JCI28968
58. Gordon LB, Kleinman ME, Miller DT, Neuberg DS, Giobbie-Hurder A, Gerhard-Herman M, Smoot LB, Gordon CM, Cleveland R, Snyder BD, Fligor B, Bishop WR, Statkevich P, Regen A, Sonis A, Riley S, Ploski C, Correia A, Quinn N, Ullrich NJ, Nazarian A, Liang MG, Huh SY, Schwartzman A, Kieran MW (2012) Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 109(41):16666-16671. doi: 10.1073/pnas.1202529109
59. Kyriakis JM, Avruch J (2012) Mammalian MAPK signal transduction pathways activated by stress and infl ammation: a 10-year update. Physiol Rev 92(2):689-737. doi: 10.1152/physrev.00028.2011
60. Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and infl ammation. Physiol Rev 81(2):807-869
61. Plotnikov A, Zehorai E, Procaccia S, Seger R (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813(9):1619-1633. doi: 10.1016/j.bbamcr.2010.12.012
62. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537-549. doi: 10.1038/nrc2694
63. Raman M, Chen W, Cobb MH (2007) Differential regulation and properties of MAPKs. Oncogene 26(22):3100-3112. doi: 10.1038/sj.onc.1210392
64. McKay MM, Morrison DK (2007) Integrating signals from RTKs to ERK/MAPK. Oncogene 26(22):3113-3121. doi: 10.1038/sj.onc.1210394
65. Ivorra C, Kubicek M, Gonzalez JM, Sanz-Gonzalez SM, Alvarez-Barrientos A, O'Connor JE, Burke B, Andres V (2006) A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. Genes Dev 20(3):307-320. doi: 10.1101/gad.349506
66. Arimura T, Helbling-Leclerc A, Massart C, Varnous S, Niel F, Lacene E, Fromes Y, Toussaint M, Mura AM, Keller DI, Amthor H, Isnard R, Malissen M, Schwartz K, Bonne G (2005) Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet 14(1):155-169. doi: 10.1093/hmg/ddi017
67. Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, Bonne G, Worman HJ (2007) Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest 117(5):1282-1293. doi: 10.1172/JCI29042
68. Muchir A, Wu W, Choi JC, Iwata S, Morrow J, Homma S, Worman HJ (2012) Abnormal p38alpha mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation. Hum Mol Genet 21(19):4325-4333. doi: 10.1093/hmg/dds265
69. Muchir A, Kim YJ, Reilly SA, Wu W, Choi JC, Worman HJ (2013) Inhibition of extracellular signal-regulated kinase 1/2 signaling has benefi cial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation. Skelet Muscle 3:17
70. Muchir A, Shan J, Bonne G, Lehnart SE, Worman HJ (2009) Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet 18(2):241-247. doi: 10.1093/hmg/ddn343
71. Wu W, Muchir A, Shan J, Bonne G, Worman HJ (2011) Mitogen-activated protein kinase inhibitors improve heart function and prevent fi brosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation 123(1):53-61. doi: 10.1161/CIRCULATIONAHA.110.970673
72. Wu W, Shan J, Bonne G, Worman HJ, Muchir A (2010) Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene. Biochim Biophys Acta 1802(7-8):632-638. doi: 10.1016/j.bbadis.2010.04.001
73. Emerson LJ, Holt MR, Wheeler MA, Wehnert M, Parsons M, Ellis JA (2009) Defects in cell spreading and ERK1/2 activation in fi broblasts with lamin A/C mutations. Biochim Biophys Acta 1792(8):810-821. doi: 10.1016/j.bbadis.2009.05. 007
74. Muchir A, Reilly SA, Wu W, Iwata S, Homma S, Bonne G, Worman HJ (2012) Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene. Cardiovasc Res 93(2):311-319. doi: 10.1093/cvr/cvr301
75. Gonzalez JM, Navarro-Puche A, Casar B, Crespo P, Andres V (2008) Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J Cell Biol 183(4):653-666. doi: 10.1083/jcb.200805049
76. Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441(7092):424-430. doi: 10.1038/nature04869
77. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16(1):3-34
78. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, Sabatini DM (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25(6):903-915. doi: 10.1016/j.molcel.2007.03.003
79. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9(3):316-323. doi: 10.1038/ncb1547
80. Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12(1):21-35. doi: 10.1038/nrm3025
81. Choi JC, Muchir A, Wu W, Iwata S, Homma S, Morrow JP, Worman HJ (2012) Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Sci Transl Med 4(144):144ra102. doi: 10.1126/scitranslmed. 3003875
82. Ramos FJ, Chen SC, Garelick MG, Dai DF, Liao CY, Schreiber KH, MacKay VL, An EH, Strong R, Ladiges WC, Rabinovitch PS, Kaeberlein M, Kennedy BK (2012) Rapamycin reverses elevated mTORC1 signaling in lamin A/C-defi cient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med 4(144):144ra103. doi: 10.1126/scitranslmed.3003802
83. Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B (1999) Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147(5):913-920
84. Jahn D, Schramm S, Schnolzer M, Heilmann CJ, de Koster CG, Schutz W, Benavente R, Alsheimer M (2012) A truncated lamin A in the Lmna-/-mouse line: implications for the understanding of laminopathies. Nucleus 3(5):463-474. doi: 10.4161/nucl.21676
85. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27-42. doi: 10.1016/j.cell.2007.12.018
86. Boguslavsky RL, Stewart CL, Worman HJ (2006) Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 15(4):653-663. doi: 10.1093/hmg/ddi480
87. Choi JC, Wu W, Muchir A, Iwata S, Homma S, Worman HJ (2012) Dual specifi city phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation. J Biol Chem 287(48):40513-40524. doi: 10.1074/jbc.M112.404541
88. Bertacchini J, Beretti F, Cenni V, Guida M, Gibellini F, Mediani L, Marin O, Maraldi NM, de Pol A, Lattanzi G, Cocco L, Marmiroli S (2013) The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression. FASEB J 27:2145. doi: 10.1096/fj.12-218214
89. Cenni V, Bertacchini J, Beretti F, Lattanzi G, Bavelloni A, Riccio M, Ruzzene M, Marin O, Arrigoni G, Parnaik V, Wehnert M, Maraldi NM, de Pol A, Cocco L, Marmiroli S (2008) Lamin A Ser404 is a nuclear target of Akt phosphorylation in C2C12 cells. J Proteome Res 7(11):4727-4735. doi: 10.1021/pr800262g
90. Worman HJ, Fong LG, Muchir A, Young SG (2009) Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 119(7):1825-1836. doi: 10.1172/JCI37679
91. Scaffi di P, Misteli T (2008) Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 10(4):452-459. doi: 10.1038/ncb1708
92. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284(5415):770-776
93. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111. doi: 10.1038/35102167
94. Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123(Pt 24):4195-4200. doi: 10.1242/jcs.023820
95. Hernandez L, Roux KJ, Wong ES, Mounkes LC, Mutalif R, Navasankari R, Rai B, Cool S, Jeong JW, Wang H, Lee HS, Kozlov S, Grunert M, Keeble T, Jones CM, Meta MD, Young SG, Daar IO, Burke B, Perantoni AO, Stewart CL (2010) Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell 19(3):413-425. doi: 10.1016/j.devcel.2010.08.013
96. Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL (2003) A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 423(6937):298-301. doi: 10.1038/nature01631
97. Miraoui H, Marie PJ (2010) Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci Signal 3(146):re9. doi: 10.1126/scisignal. 3146re9
98. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17(1):9-26. doi: 10.1016/j.devcel.2009.06.016
99. Vijg J, Campisi J (2008) Puzzles, promises and a cure for ageing. Nature 454(7208):1065-1071. doi: 10.1038/nature07216
100. Kirkwood TB (2005) Understanding the odd science of aging. Cell 120(4):437-447. doi: 10.1016/j.cell.2005.01.027
101. Ramirez CL, Cadinanos J, Varela I, Freije JM, Lopez-Otin C (2007) Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell Mol Life Sci 64(2):155-170. doi: 10.1007/s00018-006-6349-3
102. Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM, Zhou Z, Rodriguez FJ, Stewart CL, Vega JA, Tryggvason K, Freije JM, Lopez-Otin C (2005) Accelerated ageing in mice defi cient in Zmpste24 protease is linked to p53 signalling activation. Nature 437(7058):564-568. doi: 10.1038/nature04019
103. Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, Pei D, Pendas AM, Cadinanos J, Lopez-Otin C, Tse HF, Hutchison C, Chen J, Cao Y, Cheah KS, Tryggvason K, Zhou Z (2005) Genomic instability in laminopathy-based premature aging. Nat Med 11(7):780-785. doi: 10.1038/nm1266
104. Burtner CR, Kennedy BK (2010) Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol 11(8):567-578. doi: 10.1038/nrm2944
105. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132(3):344-362. doi: 10.1016/j.cell.2008.01.020
106. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8(1):49-62. doi: 10.1038/nrm2083
107. Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E, Chang HY (2007) Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev 21(24):3244-3257. doi: 10.1101/gad.1588507
108. Tak PP, Firestein GS (2001) NF-kappaB: a key role in infl ammatory diseases. J Clin Invest 107(1):7-11. doi: 10.1172/JCI11830
109. Osorio FG, Barcena C, Soria-Valles C, Ramsay AJ, de Carlos F, Cobo J, Fueyo A, Freije JM, Lopez-Otin C (2012) Nuclear lamina defects cause ATM-dependent NF-kappaB activation and link accelerated aging to a systemic infl ammatory response. Genes Dev 26(20):2311-2324. doi: 10.1101/gad.197954.112
110. Laguri C, Gilquin B, Wolff N, Romi-Lebrun R, Courchay K, Callebaut I, Worman HJ, Zinn-Justin S (2001) Structural characterization of the LEM motif common to three human inner nuclear membrane proteins. Structure 9(6):503-511
111. Ostlund C, Ellenberg J, Hallberg E, Lippincott-Schwartz J, Worman HJ (1999) Intracellular traffi cking of emerin, the Emery-Dreifuss muscular dystrophy protein. J Cell Sci 112(Pt 11):1709-1719
112. Clements L, Manilal S, Love DR, Morris GE (2000) Direct interaction between emerin and lamin A. Biochem Biophys Res Commun 267(3):709-714. doi: 10.1006/bbrc.1999.2023
113. Raharjo WH, Enarson P, Sullivan T, Stewart CL, Burke B (2001) Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J Cell Sci 114(Pt 24):4447-4457
114. Vaughan A, Alvarez-Reyes M, Bridger JM, Broers JL, Ramaekers FC, Wehnert M, Morris GE, Whitfield WGF, Hutchison CJ (2001) Both emerin and lamin C depend on lamin A for localization at the nuclear envelope. J Cell Sci 114(Pt 14):2577-2590
115. Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13(1):11-26. doi: 10.1038/nrc3419
116. Markiewicz E, Tilgner K, Barker N, van de Wetering M, Clevers H, Dorobek M, Hausmanowa-Petrusewicz I, Ramaekers FC, Broers JL, Blankesteijn WM, Salpingidou G, Wilson RG, Ellis JA, Hutchison CJ (2006) The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. EMBO J 25(14):3275-3285. doi: 10.1038/sj.emboj. 7601230
117. Neumann S, Schneider M, Daugherty RL, Gottardi CJ, Eming SA, Beijer A, Noegel AA, Karakesisoglou I (2010) Nesprin-2 interacts with {alpha}-catenin and regulates Wnt signaling at the nuclear envelope. J Biol Chem 285(45):34932-34938. doi: 10.1074/jbc.M110.119651
118. Wu W, Lin F, Worman HJ (2002) Intracellular traffi cking of MAN1, an integral protein of the nuclear envelope inner membrane. J Cell Sci 115(Pt 7):1361-1371
119. Lin F, Blake DL, Callebaut I, Skerjanc IS, Holmer L, McBurney MW, Paulin-Levasseur M, Worman HJ (2000) MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin. J Biol Chem 275(7):4840-4847
120. Paulin-Levasseur M, Blake DL, Julien M, Rouleau L (1996) The MAN antigens are nonlamin constituents of the nuclear lamina in vertebrate cells. Chromosoma 104(5):367-379
121. Lee KK, Gruenbaum Y, Spann P, Liu J, Wilson KL (2000) C. Elegans nuclear envelope proteins emerin, MAN1, lamin, and nucleoporins reveal unique timing of nuclear envelope breakdown during mitosis. Mol Biol Cell 11(9):3089-3099
122. Mansharamani M, Wilson KL (2005) Direct binding of nuclear membrane protein MAN1 to emerin in vitro and two modes of binding to barrier-to- autointegration factor. J Biol Chem 280(14):13863-13870. doi: 10.1074/jbc.M413020200
123. Massague J (2012) TGFbeta signalling in context. Nat Rev Mol Cell Biol 13(10):616-630. doi: 10.1038/nrm3434
124. Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJ, Savarirayan R, Van Hul W, Vanhoenacker F, Huylebroeck D, De Paepe A, Naeyaert JM, Vandesompele J, Speleman F, Verschueren K, Coucke PJ, Mortier GR (2004) Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet 36(11):1213-1218. doi: 10.1038/ng1453
125. Lin F, Morrison JM, Wu W, Worman HJ (2005) MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factorbeta signaling. Hum Mol Genet 14(3):437-445. doi: 10.1093/hmg/ddi040
126. Pan D, Estevez-Salmeron LD, Stroschein SL, Zhu X, He J, Zhou S, Luo K (2005) The integral inner nuclear membrane protein MAN1 physically interacts with the R-Smad proteins to repress signaling by the transforming growth factor-{beta} superfamily of cytokines. J Biol Chem 280(16):15992-16001. doi: 10.1074/jbc.M411234200
127. Cohen TV, Kosti O, Stewart CL (2007) The nuclear envelope protein MAN1 regulates TGFbeta signaling and vasculogenesis in the embryonic yolk sac. Development 134(7):1385-1395. doi: 10.1242/dev.02816
128. Ishimura A, Ng JK, Taira M, Young SG, Osada S (2006) Man1, an inner nuclear membrane protein, regulates vascular remodeling by modulating transforming growth factor beta signaling. Development 133(19):3919-3928. doi: 10.1242/dev.02538
129. Bourgeois B, Gilquin B, Tellier-Lebègue C, Östlund C, Wu W, Pérez J, El Hage P, Lallemand F, Worman HJ, Zinn-Justin S (2013) Inhibition of transforming growth factor-b signaling at the nuclear envelope: characterization of MAN1-Smad2/3-PPM1A interactions. Sci Signal 6:ra49
130. Raju GP, Dimova N, Klein PS, Huang HC (2003) SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1. J Biol Chem 278(1):428-437. doi: 10.1074/jbc.M210505200
131. Diamond DA, Berry SJ, Umbricht C, Jewett HJ, Coffey DS (1982) Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer. Prostate 3(4):321-332